After 9 months of recruiting women who are looking for pregnancy, we have finally passed our milestone with 403 patients screened and 356 randomized in the #OXOART2 study!
There is still work to be done in this #clinicaltrial but we want to thank all the patients and centres in Spain (@IVI RMA GLOBAL (Mallorca, Valencia, Madrid, Barcelona, Seville, Bilbao, Zaragoza), @Ginemed (Sevilla), @Quirónsalud (Barcelona, Madrid), @Dexeus mujer (Barcelona), @Fertty (Barcelona), @Instituto Bernabeu (Madrid, Alicante) and @Clínica Ginefiv (Madrid)), and also the centres in the Czech Republic (@IVF CUBE, Sanatorium @PRONATAL, @ISCARE IVF SK, @Klinika reprodukční medicíny a gynekologie IVF Zlín, Fertimed s.r.o., Pronatal NORD and @UNICA Clinic) and Poland (VitroLive Sp. z o.o, Przychodnia Lekarska nOvum and KRIOBANK) for making the advancement of the #OXO-001 treatment and all the work done during this period of time.
Thank you very much and congratulations!!